CLOV Clover Health Investments Corp

$CLOV this stock has me excited tomorrow. Let’s start the week crossing five for good and never look back

$CLOV I thought I was having one of the worst Fridays in years… Then I opened my portfolio, saw CLOV, and suddenly nothing else mattered. 😂💚 In CLOV we trust!

$CLOV Counterpart is not just an internal tool anymore—it is an exportable, high-margin clinical operating system that major health networks are actively buying to survive the transition to value-based care.

$CLOV Clover Health is a PROFITABLE GROWTH engine that has NO debt. This is powerful going forward!

$CLOV Gotta punch through the resistance at $5.21 ,severeal times has been tested but has hold above and stay above .Then we will be off to the races ,other institution only purchase obove 5 bucks .

$CLOV $CLOV At roughly $4.69 per share ($2.49 billion market cap), $CLOV trades at roughly 0.83x its $3 billion+ 2026 revenue run rate—and roughly 0.66x enterprise-value-to-sales once you strip out its $512.6 million cash pile. Paying less than 1x sales for a self-funding company compounding revenue at 53% year-over-year with GAAP net profitability and high-margin SaaS optionality is one of the sharpest mispricings on the market. A re-rating is IMMINENT! ✅

$CLOV if this goes to 30 I’m a millionaire & can finally retire! Need it to happen soon please!!Lfg🍀🍀🍀

$CLOV it’s the elusive Dragon chart! Known for its fire breathing breakouts. They call it “Mortocum”.

$CLOV you all smell a change in the air? A Friday buy up instead of the normal Friday sell off?!?!?!?

$CLOV The setup I keep coming back to is a combo: 1. GAAP profitability in the insurance business. 2. Counterpart Health as its own revenue line. Either one alone gets a shrug from the market. Insurance profit alone looks like a small MA plan having a good year. Counterpart alone looks like a promising tool without proof. Together it's a different company: an insurer that funds itself plus a software business with external customers.

$CLOV most upside potential of any stock I have ever held … already drawing enough from other annuities to enjoy relaxing retirement … my CLOV shares can sit here as long as necessary … $100 a share is my sell price … IMHO and IDGAF …

$CLOV Iowa clinic ending 30 year partnership with UnityPoint health but not with Counterpart. interesting

$CLOV We all know these HEDGIE parasites can easily nullify this pop with their ever more unscrupulous tactics … but it’s nice to see us over $5 again … even if temporarily … I believe if not for their constant effort we would be close to $10 than $5 … IMHO …

$CLOV By the way folks. There's that 4.79-4.81 resistance line again. Next spot to watch out for is 5.10-5.12. If we get over that one -- sorry -- WHEN we get over that one, we're in for a good run. Buckle up, and be careful what strike you're picking if you're selling calls.

$CLOV So, to answer your question about whether Andrew would buy shares, he indirectly did by terminating his 10b5-1 trading plan.

$CLOV you know diluting the stock back then instead of now is a good reason no debt. They timed the market for themselves for lending to build out a business.

$CLOV 50 4.5 puts expires worthlessly, sold about a week a go, 10% gain in a week, i love Clov. In Toy we trust!

$CLOV What’ll happen to the stock on Q1 2027 when they announce $1.15-1.2b quarterly at current growth? That’s .50 p/s ratio at current market cap. I expect them to grow even more but even at current growth, this extremely undervalued. Not to mention I expect a 2x p/s ratio before SAAS so we should be $5-10b market cap easily next year at 1-2x p/s ratio. $10-20+ stock before SAAS.

$CLOV You do not own enough bro. You know what’s happening. The domains were the heads up and it’s been proven in various ways.

$CLOV • Clover Health (CLOV): $0 Long-Term Debt • UnitedHealth Group (UNH): Over $60 Billion in debt. • CVS Health / Aetna (CVS): Over $60 Billion in debt. • Humana (HUM): Over $12 Billion in debt.